nodes	percent_of_prediction	percent_of_DWPC	metapath
Methohexital—Cardio-respiratory arrest—Vandetanib—thyroid cancer	0.205	0.205	CcSEcCtD
Methohexital—Bronchospasm—Vandetanib—thyroid cancer	0.0452	0.0452	CcSEcCtD
Methohexital—Convulsion—Vandetanib—thyroid cancer	0.0278	0.0278	CcSEcCtD
Methohexital—Anxiety—Vandetanib—thyroid cancer	0.0272	0.0272	CcSEcCtD
Methohexital—Dyspnoea—Vandetanib—thyroid cancer	0.0233	0.0233	CcSEcCtD
Methohexital—Injection site pain—Epirubicin—thyroid cancer	0.0224	0.0224	CcSEcCtD
Methohexital—Erythema—Sorafenib—thyroid cancer	0.0216	0.0216	CcSEcCtD
Methohexital—Gastrointestinal pain—Vandetanib—thyroid cancer	0.0214	0.0214	CcSEcCtD
Methohexital—Delirium—Epirubicin—thyroid cancer	0.0212	0.0212	CcSEcCtD
Methohexital—Injection site pain—Doxorubicin—thyroid cancer	0.0207	0.0207	CcSEcCtD
Methohexital—Abdominal pain—Vandetanib—thyroid cancer	0.0207	0.0207	CcSEcCtD
Methohexital—Delirium—Doxorubicin—thyroid cancer	0.0197	0.0197	CcSEcCtD
Methohexital—Pruritus—Vandetanib—thyroid cancer	0.0185	0.0185	CcSEcCtD
Methohexital—Hiccups—Epirubicin—thyroid cancer	0.0183	0.0183	CcSEcCtD
Methohexital—Salivary hypersecretion—Epirubicin—thyroid cancer	0.0177	0.0177	CcSEcCtD
Methohexital—Anaphylactic shock—Sorafenib—thyroid cancer	0.0176	0.0176	CcSEcCtD
Methohexital—Shock—Sorafenib—thyroid cancer	0.0174	0.0174	CcSEcCtD
Methohexital—Hiccups—Doxorubicin—thyroid cancer	0.0169	0.0169	CcSEcCtD
Methohexital—Vomiting—Vandetanib—thyroid cancer	0.0166	0.0166	CcSEcCtD
Methohexital—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.0164	0.0164	CcSEcCtD
Methohexital—Headache—Vandetanib—thyroid cancer	0.0164	0.0164	CcSEcCtD
Methohexital—Dyspnoea—Sorafenib—thyroid cancer	0.0157	0.0157	CcSEcCtD
Methohexital—Nausea—Vandetanib—thyroid cancer	0.0155	0.0155	CcSEcCtD
Methohexital—Thrombophlebitis—Epirubicin—thyroid cancer	0.0153	0.0153	CcSEcCtD
Methohexital—Gastrointestinal pain—Sorafenib—thyroid cancer	0.0144	0.0144	CcSEcCtD
Methohexital—Thrombophlebitis—Doxorubicin—thyroid cancer	0.0142	0.0142	CcSEcCtD
Methohexital—Urticaria—Sorafenib—thyroid cancer	0.014	0.014	CcSEcCtD
Methohexital—Abdominal pain—Sorafenib—thyroid cancer	0.0139	0.0139	CcSEcCtD
Methohexital—Pruritus—Sorafenib—thyroid cancer	0.0125	0.0125	CcSEcCtD
Methohexital—Liver function test abnormal—Epirubicin—thyroid cancer	0.0122	0.0122	CcSEcCtD
Methohexital—Liver function test abnormal—Doxorubicin—thyroid cancer	0.0113	0.0113	CcSEcCtD
Methohexital—Vomiting—Sorafenib—thyroid cancer	0.0112	0.0112	CcSEcCtD
Methohexital—Headache—Sorafenib—thyroid cancer	0.011	0.011	CcSEcCtD
Methohexital—Nausea—Sorafenib—thyroid cancer	0.0105	0.0105	CcSEcCtD
Methohexital—Rhinitis—Epirubicin—thyroid cancer	0.0092	0.0092	CcSEcCtD
Methohexital—Rhinitis—Doxorubicin—thyroid cancer	0.00851	0.00851	CcSEcCtD
Methohexital—Erythema—Epirubicin—thyroid cancer	0.00799	0.00799	CcSEcCtD
Methohexital—Erythema—Doxorubicin—thyroid cancer	0.00739	0.00739	CcSEcCtD
Methohexital—Agitation—Epirubicin—thyroid cancer	0.00734	0.00734	CcSEcCtD
Methohexital—Convulsion—Epirubicin—thyroid cancer	0.00692	0.00692	CcSEcCtD
Methohexital—Agitation—Doxorubicin—thyroid cancer	0.00679	0.00679	CcSEcCtD
Methohexital—Anxiety—Epirubicin—thyroid cancer	0.00678	0.00678	CcSEcCtD
Methohexital—Anaphylactic shock—Epirubicin—thyroid cancer	0.00652	0.00652	CcSEcCtD
Methohexital—Shock—Epirubicin—thyroid cancer	0.00641	0.00641	CcSEcCtD
Methohexital—Convulsion—Doxorubicin—thyroid cancer	0.0064	0.0064	CcSEcCtD
Methohexital—Tachycardia—Epirubicin—thyroid cancer	0.00636	0.00636	CcSEcCtD
Methohexital—Anxiety—Doxorubicin—thyroid cancer	0.00627	0.00627	CcSEcCtD
Methohexital—Hypotension—Epirubicin—thyroid cancer	0.00609	0.00609	CcSEcCtD
Methohexital—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00603	0.00603	CcSEcCtD
Methohexital—Shock—Doxorubicin—thyroid cancer	0.00593	0.00593	CcSEcCtD
Methohexital—Tachycardia—Doxorubicin—thyroid cancer	0.00589	0.00589	CcSEcCtD
Methohexital—Dyspnoea—Epirubicin—thyroid cancer	0.00581	0.00581	CcSEcCtD
Methohexital—Hypotension—Doxorubicin—thyroid cancer	0.00564	0.00564	CcSEcCtD
Methohexital—Dyspnoea—Doxorubicin—thyroid cancer	0.00538	0.00538	CcSEcCtD
Methohexital—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00533	0.00533	CcSEcCtD
Methohexital—Urticaria—Epirubicin—thyroid cancer	0.00518	0.00518	CcSEcCtD
Methohexital—Abdominal pain—Epirubicin—thyroid cancer	0.00515	0.00515	CcSEcCtD
Methohexital—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00493	0.00493	CcSEcCtD
Methohexital—Urticaria—Doxorubicin—thyroid cancer	0.00479	0.00479	CcSEcCtD
Methohexital—Abdominal pain—Doxorubicin—thyroid cancer	0.00477	0.00477	CcSEcCtD
Methohexital—Pruritus—Epirubicin—thyroid cancer	0.00461	0.00461	CcSEcCtD
Methohexital—Pruritus—Doxorubicin—thyroid cancer	0.00427	0.00427	CcSEcCtD
Methohexital—Vomiting—Epirubicin—thyroid cancer	0.00414	0.00414	CcSEcCtD
Methohexital—Headache—Epirubicin—thyroid cancer	0.00408	0.00408	CcSEcCtD
Methohexital—Nausea—Epirubicin—thyroid cancer	0.00387	0.00387	CcSEcCtD
Methohexital—Vomiting—Doxorubicin—thyroid cancer	0.00383	0.00383	CcSEcCtD
Methohexital—Headache—Doxorubicin—thyroid cancer	0.00378	0.00378	CcSEcCtD
Methohexital—Nausea—Doxorubicin—thyroid cancer	0.00358	0.00358	CcSEcCtD
